Filtros de búsqueda

Lista de obras de

"Tree in bud" attributable to organising pneumonia ⬇️

artículo científico publicado el 27 de julio de 2012

A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

artículo científico publicado en 2018

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

artículo científico publicado en 2017

Acetylcysteine in IPF: the knockout blow?

artículo científico publicado en 2016

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation

artículo científico publicado en 2020

Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

scientific article published on 30 September 2019

Challenges in the classification of fibrotic ILD.

artículo científico

Challenges in the classification of fibrotic ILD: Patient case 2.

artículo científico publicado en 2015

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry

scientific article published on 05 May 2018

Clubbing in patients with fibrotic interstitial lung diseases

artículo científico publicado en 2017

Comprehensive Care for Patients with Sarcoidosis

artículo científico publicado en 2020

Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease

scientific article published on 01 July 2019

Cough in idiopathic pulmonary fibrosis

artículo científico publicado en 2016

Cultural Differences in Palliative Care in Patients With Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2015

Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis

artículo científico publicado en 2018

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study

artículo científico publicado en 2018

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

artículo científico publicado en 2020

Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).

artículo científico publicado en 2017

Development and feasibility of an eHealth-tool for Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2018

Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis

scientific article published on 01 November 2019

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

artículo científico publicado en 2017

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis

artículo científico publicado en 2015

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial

artículo científico publicado en 2018

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis

scientific article published on 30 September 2019

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis

scientific article published on 24 October 2019

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers

artículo científico publicado en 2015

European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity

artículo científico publicado en 2016

Evaluation of a Home Monitoring Application for Follow Up after Lung Transplantation-A Pilot Study

artículo científico publicado en 2020

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis

scientific article published on 05 May 2019

Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.

artículo científico publicado en 2018

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative

scientific article published on 18 February 2019

Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey

artículo científico publicado en 2019

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials

artículo científico publicado en 2020

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views

artículo científico publicado en 2018

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease

scientific article published on 12 December 2019

Idiopathic pulmonary fibrosis: new insights

artículo científico publicado en 2015

Increased T helper 17.1 cells in sarcoidosis mediastinal lymph nodes.

artículo científico publicado en 2018

Inflammation and immunity in IPF pathogenesis and treatment.

artículo científico publicado en 2019

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2017

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study

artículo científico publicado en 2019

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension

artículo científico publicado en 2021

Medical Therapy in Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2016

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design

scientific article published on 29 September 2019

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners

artículo científico publicado en 2018

New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis: only PROMises?

artículo científico publicado en 2016

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events

artículo científico publicado en 2018

No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis

artículo científico publicado en 2017

Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey

artículo científico publicado en 2019

Palliative care in interstitial lung disease: living well.

artículo científico publicado en 2017

Patient and partner empowerment programme for idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

scientific article published on 23 July 2020

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

artículo científico publicado en 2015

Physiological Predictors of Survival in Patients with Sarcoidosis Associated Pulmonary Hypertension: Results from an International Registry

scientific article published on 26 March 2020

Progress in the treatment of pulmonary fibrosis

artículo científico publicado en 2020

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

scientific article published on 02 August 2019

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).

artículo científico publicado en 2019

Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis ⬇️

artículo científico publicado el 4 de febrero de 2013

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

artículo científico publicado en 2019

Research highlights from the 2018 ERS International Congress: interstitial lung diseases

article

Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes

scientific article published on 30 October 2019

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis

scientific article published on 02 August 2018

Scalp hair cortisol and testosterone levels in patients with sarcoidosis.

artículo científico publicado en 2019

Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials

scientific article published on 13 March 2019

Spectrum of Fibrotic Lung Diseases

scientific article published on 01 September 2020

Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2018

Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end

artículo científico publicado en 2018

Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe?

artículo científico publicado en 2018

The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis

artículo científico publicado en 2019

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study

scientific article published on 07 March 2019

The impact of the new Global Lung Function Initiative T LCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis

artículo científico publicado en 2019

Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.

artículo científico publicado en 2016

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis

artículo científico publicado en 2016

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns

artículo científico publicado en 2016

Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire

scientific article published on 01 February 2019

What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany

scientific article published on January 2017

[German Validation of the "King's Brief Interstitial Lung Disease (K-Bild) Health Status Questionnaire"]

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda